Cure My Disease

Don't miss your cure!

 Log in / Sign up

AI chatbot aims to teach women heart attack symptoms

NCT ID NCT07416734

Not yet recruiting Knowledge-focused Sponsor: University of California, San Francisco Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether an AI-powered app called HeartBot II can improve women's awareness of heart attack symptoms. About 200 women will be randomly assigned to use the app right away or wait 12 weeks. Participants complete surveys about their knowledge and confidence in recognizing a heart attack.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

HeartBot II app (AI chatbot program)

What this could lead to

If it works, this could lead to a simple, scalable tool to help women recognize heart attack symptoms and seek emergency care faster.

What could go wrong

This is a small, early-stage study focused on awareness, not on actual health outcomes. The app may not change behavior or reduce heart attack deaths.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PARTICIPANTS MUST BE WOMEN AGED 25 YEARS OR OLDER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Alzheimer disease heart disorder stroke disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

PARTICIPANTS MUST BE WOMEN AGED 25 YEARS OR OLDER PARTICIPANTS SHOULD HAVE NO SELF-REPORTED HISTORY OF HEART DISEASE OR STROKE PARTICIPANTS SHOULD HAVE NO TERMINAL ILLNESS OR DIAGNOSED COGNITIVE IMPAIRMENT, INCLUDING ALZHEIMER'S DISEASE PARTICIPANTS SHOULD NOT BE A HEALTHCARE PROFESSIONALS OR HEALTHCARE TRAINEES PARTICIPANTS SHOULD NOT BE EMPLOYED IN THE HEALTHCARE FIELD PARTICIPANTS SHOULD POSSESS A SMARTPHONE WITH AN ACTIVE DATA PLAN OR ACCESS TO WI-FI PARTICIPANTS SHOULD RESIDE IN THE UNITED STATES AND BE A UNIVERSITY OF CALIFORNIA, SAN FRANCISCO HEALTH PATIENT

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • University of California, San Francisco

    San Francisco, California, 94143, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••